WRAPUP 3-WHO backs use of experimental Ebola drugs in West Africa

Tue Aug 12, 2014 6:41pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

* Liberia to treat infected doctors with trial drug ZMapp

* Spanish priest who received ZMapp dies in Madrid

* No licensed treatments or vaccines for Ebola

* Ghana delays academic year for tertiary institutions (Adds Canada to donate Ebola vaccine)

By Kate Kelland and Stephanie Nebehay

LONDON/GENEVA, Aug 12 (Reuters) - People infected in the West African Ebola outbreak can be offered untested drugs, the World Health Organisation said on Tuesday, but the scarcity of supplies has raised questions about who gets priority access to treatment.

Liberia said it planned to treat two infected doctors with an unproven Ebola medicine called ZMapp. They would become the first Africans to receive the drug, which has been given to a Spanish priest who later died and two U.S. aid workers.

The outbreak is the world's largest and deadliest and the U.N. agency last week declared it an international health emergency. The WHO has appealed for funds and medical staff to supplement health care in one of the poorest regions in the world.

So far, 1,013 people have died, the vast majority in Guinea, Liberia and Sierra Leone. Two have died in Nigeria.   Continued...